top of page
WEIGHT LOSS PROGRAMS,
BACKED BY SCIENCE
AS SEEN ON
THE SCIENCE
GLP-1 Class Medications | Semaglutide & Tirzepatide
Semaglutide and Tirzepatide are third and fourth-generation GLP-1 and GLP-1/GIP peptides that mimic the body’s natural gut hormones and act on specific brain areas that regulate hunger, reducing appetite and shifting body weight set point.
PEOPLE DON’T FAIL DIETS.
DIETS FAIL PEOPLE.
The verdict
Revolutionary and most effective medication class for lasting weight loss currently available on the market, non-habit forming, and extremely safe.
Significant results
In clinic trials, individuals using once weekly Semaglutide lost an average of 15% of their body weight, with 1 in 3 patients losing 20%+ in 68 weeks. Patients on once-weekly Tirzepatide lost an average of 24.3% of their body weight in 72 weeks. Reduced-calorie diet and increased physical activity were implemented in both studies.
Reduced side effects
Even though GLP-1s have an extreme safety profile and are tolerated well, the most common side effects associated with the GLP-1 class of medications are nausea and gastrointestinal distress. We utilize compounded Semaglutide with Vitamin B12 or Vitamin B6, which have clinically shown to minimize these associated symptoms, leading to better tolerance and compliance.
bottom of page